THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Founder & CEO

Clinical resource

Methamphetamine Use Disorder: Assessment, Treatment and Recovery

Methamphetamine use disorder needs more than withdrawal management. Learn what assessment should cover, which treatments have the strongest evidence, when urgent care is necessary, and how families and continuing support can help.

Clinically reviewed byDr. Sarah Boss, MD
Stone residence with a swimming pool, lawn and palm trees

If methamphetamine use is becoming difficult to control, an assessment can help identify the risks and appropriate next steps. You do not have to decide on a treatment program before asking for help. This guide explains assessment, withdrawal, care choices, and recovery support, while distinguishing planned treatment from emergencies. It is educational information, not an individual diagnosis or medication plan.

Understanding Methamphetamine Use Disorder

Methamphetamine is a potent stimulant that affects alertness, energy, appetite, and the brain’s reward pathways. Crystal meth is one illicit form. People may use it for pleasure, to stay awake, to cope with distress, or in sexual settings. Understanding what use provides for someone helps identify what treatment must address; it does not make the risks less important. [2]

Methamphetamine use disorder involves a pattern of use causing significant impairment or distress. Features can include difficulty controlling use, unsuccessful efforts to reduce it, craving, neglected responsibilities, and continued use despite harm. Tolerance and withdrawal may occur, but neither alone describes the whole disorder. Diagnosis requires a clinical assessment rather than assumptions about appearance or employment. [2]

For an appointment, bring concrete examples: staying awake through workdays, repeatedly spending more than intended, or returning to use after deciding not to. The wider drug-related resource collection provides context for discussing different substances without treating all drug problems as interchangeable.

Recognizing an Emergency

Call 911 for chest pain, a seizure, collapse, severe breathing difficulty, very high body temperature, or sudden symptoms suggesting a stroke. Severe agitation, confusion, or paranoia that makes the situation unsafe also needs emergency assessment. Tell responders what may have been taken and when, but do not delay the call while gathering details. [3]

If someone is unresponsive and not breathing normally, call 911 and begin CPR immediately, following dispatcher instructions. This applies regardless of which substance was used. Separately, give naloxone according to its instructions if opioid involvement is possible and it is available, without interrupting CPR. Naloxone does not reverse stimulant toxicity. [1], [4]

Do not confront, crowd, or try to physically restrain a severely agitated person. Keep yourself safe and follow emergency-dispatch advice. For suicidal thoughts or emotional crisis in the United States, call or text 988; immediate danger requires 911. THE BALANCE is not an emergency service, and a planned consultation must not delay local emergency care. [3], [10]

What a Thorough Assessment Should Cover

Assessment starts with urgent physical and psychiatric risks, then examines the substance-use history, mental state, physical health, and everyday circumstances. Useful details include the last use, frequency, route, binge patterns, previous overdoses, withdrawal experiences, and earlier treatment. Clinicians also need the complete medication and substance list, including products of uncertain origin. [1], [2]

Expect questions about sleep, mood, concentration, sexual health, relationships, work, housing, and personal safety. Depending on symptoms and history, examinations and tests may assess cardiovascular problems, infection, or other complications. Drug testing can contribute information, but a result cannot replace the clinical history or establish the severity of a use disorder by itself. [2], [5]

Prepare a short account of what has changed and what you want help with. Bring medication packaging and relevant medical records when available. Ask how testing will inform care, who will coordinate decisions, and whether another specialist is needed. You can also explain practical barriers, such as transport, caregiving duties, or difficulty attending appointments after a binge.

Withdrawal and the Early Recovery Period

Stopping after repeated use can bring exhaustion, low mood, irritability, increased appetite, disturbed sleep, and strong cravings. Some people initially sleep much more, while others struggle with insomnia. Symptoms can vary and require individual assessment. Severe depression and suicidal thinking are particularly important safety concerns. [5]

Some post-acute symptoms, including depression, anxiety, insomnia, and paranoia, can persist for weeks to months. This does not mean that everyone follows the same timeline or that every symptom is withdrawal. Clinicians should assess persistent difficulties and treat them where appropriate, including investigating an independent mental health or medical condition. [1]

Ask for a plan covering contact between appointments, worsening mood, inability to manage basic needs, and urgent warning signs. Discuss which work or family responsibilities need temporary adjustment. Do not use alcohol, opioids, or nonprescribed sedatives to manage the crash. Withdrawal support is a starting point, not a complete treatment for the pattern of use. [5], [9]

Behavioral Treatment: What to Ask For

Contingency management has the strongest treatment evidence for stimulant use disorders and should be a primary component of care alongside other psychosocial treatment. It uses planned incentives linked to agreed, measurable treatment goals, such as attendance or evidence of abstinence. This is a structured clinical intervention, not an informal promise that a family member will reward someone for stopping. [1], [6]

Approaches based on cognitive behavioral therapy, community reinforcement, and the Matrix Model may also contribute to treatment. For methamphetamine use, the practical focus is on interrupting binges, responding to cravings, recognizing high-risk situations, and building rewarding activities that do not revolve around the drug. These approaches have different evidence bases and should not be presented as equally proven substitutes for contingency management. [6]

Ask a prospective program whether it provides contingency management or can arrange access elsewhere, how goals are agreed, and how progress is reviewed. Also ask what happens after missed appointments or renewed use. A description of counseling alone is not enough to establish that a program delivers evidence-based stimulant treatment.

Medication Options and Evidence Limits

There is currently no FDA-approved medication specifically for stimulant use disorders. That does not mean medical care has no role. Prescribers may consider selected off-label options, while separately treating conditions such as depression or psychosis when indicated. Ask what a proposed medicine is intended to improve and how its benefits and adverse effects will be monitored. [1], [7]

A randomized trial in adults with moderate or severe methamphetamine use disorder found that extended-release injectable naltrexone combined with oral extended-release bupropion produced a higher response than placebo. However, overall response was limited, and the trial did not establish a guaranteed recovery treatment. Its findings concern a monitored medication combination, not either medicine borrowed or used independently. [8]

Before considering medication, disclose opioid use and every prescription or nonprescribed substance. Ask about eligibility, interactions, monitoring, cost, and continuing access. Do not start, stop, or combine medicines based on this article. Be cautious about claims that supplements, rapid detoxification, or a proprietary treatment can reliably repair the brain or eliminate addiction. Such promises exceed established evidence. [6]

Mental Health, Physical Health, and Other Substances

Depression, anxiety, trauma-related symptoms, ADHD, and other substance-use disorders may coexist with methamphetamine problems. Some symptoms begin before stimulant use; others appear during intoxication or withdrawal. The sequence matters, but care should not dismiss distress until someone has been abstinent for an arbitrary period. Substance use and co-occurring conditions need coordinated assessment and treatment. [1], [5]

Physical care may include attention to heart symptoms, nutrition, dental problems, skin infections, and infection risks associated with injection or sexual exposure. Tell the clinician about pregnancy or possible pregnancy promptly so care can be coordinated appropriately. Ask which concerns the treating team can manage and which require external medical, dental, or other specialist services. [5]

Using stimulants does not cancel opioid sedation or make combinations safe. If opioids are involved, discuss overdose prevention and read the guide to opioid addiction and treatment. If benzodiazepines are regularly used to sleep after binges, their withdrawal requires separate planning; benzodiazepine withdrawal and clinical support explains why abrupt, unsupported stopping can be dangerous. [5]

Choosing Outpatient, Residential, or Hospital Care

The appropriate setting depends on current risk, medical and psychiatric needs, support at home, and the provider’s capabilities. Hospital treatment may be necessary for severe intoxication, dangerous psychosis, or serious physical complications. Once immediate risks are addressed, ongoing treatment can be organized in an outpatient or residential setting according to individual needs. [1], [5]

When comparing programs, ask who assesses suitability, what monitoring is available, and how deterioration is handled. Find out whether the service can manage co-occurring conditions, provide or arrange evidence-based stimulant treatment, and coordinate local follow-up. The guide comparing residential treatment with inpatient hospital care explains why an overnight stay does not automatically mean hospital-level care.

THE BALANCE’s private drug addiction treatment overview describes a European residential care context, not a US emergency or hospital pathway. US readers considering planned European treatment should clarify suitability, travel readiness, costs, prescribing arrangements, and return-home care before committing. Do not assume that any provider offers every specialist intervention simply because it treats addiction.

How Family and Friends Can Help

Choose a calm time to describe specific concerns and offer practical help reaching an assessment. For example: “You have barely slept, and I am worried about your health. Can we arrange medical advice?” Avoid debating whether the person looks like someone with addiction. Ask what would make the next appointment easier, while being clear about safety and household boundaries.

With the person’s consent, discuss what information relatives can receive and how they can share concerns with clinicians. Ask for guidance on responding to renewed use, paranoia, or worsening depression. Relatives should not be expected to diagnose symptoms, prescribe medication, or supervise a dangerous crisis. Family involvement can support care, but it needs an agreed role rather than constant surveillance. [9]

Protect children and other vulnerable household members from exposure to drugs or unsafe behavior. Family members may need their own counseling, support, or respite. It is reasonable to set boundaries around money, driving, or behavior at home, while avoiding threats to withhold emergency help. Joint sessions should be considered only when participation is safe and appropriate. [9]

Building a Recovery Plan That Works at Home

Recovery planning should translate treatment into everyday arrangements: appointments, a workable sleep routine, regular meals, safer relationships, and meaningful activities. Identify situations connected with methamphetamine use, including certain contacts, late-night work, sexual settings, or access to money. Agree specific alternatives with the treatment team rather than relying on a general intention to avoid temptation. [9]

If use happens again, seek medical help for concerning symptoms and contact the treating clinician promptly. A review can examine what preceded the episode, whether the level of care remains appropriate, and what support needs strengthening. Track progress beyond abstinence alone, including safer behavior, treatment engagement, health, and functioning, without minimizing the goal of stopping harmful use. [9]

Before leaving a program, ask for named follow-up clinicians, appointment dates, medication arrangements where relevant, and clear crisis contacts. Plan for weekends, travel, and missed appointments, not only ideal weeks. The next step can be a local medical or addiction-service assessment. You do not need to wait until every part of life has deteriorated before asking for help.

Questions

Frequently Asked Questions

Can someone have methamphetamine use disorder without using every day?

Yes. Diagnosis concerns impaired control and consequences, not daily use alone. Repeated binges, unsuccessful attempts to stop, or continuing despite harm can warrant assessment even when there are days or weeks without use. Describe the whole pattern to a clinician. [2]

How long does methamphetamine withdrawal last?

There is no reliable deadline for everyone. Early exhaustion and changes in sleep may be followed by continuing mood problems and cravings. Some post-acute symptoms last weeks to months. Persistent or worsening symptoms need assessment rather than an assumption that they are harmless withdrawal. [1], [5]

Is there an FDA-approved medication for methamphetamine use disorder?

No medication is currently FDA approved specifically for stimulant use disorders. Clinicians may consider selected medicines off label, meaning outside an approved indication, after reviewing risks and potential benefits. Medication decisions do not replace evidence-based behavioral treatment. [7]

Does methamphetamine-related paranoia mean permanent psychosis?

Not necessarily. Psychosis can occur with stimulant use, but its course varies. Continuing symptoms require psychiatric assessment because clinicians must consider substance effects and other conditions. Severe paranoia, hallucinations, or unsafe behavior should not be managed by waiting at home for a predicted recovery date. [5]

Can naloxone reverse a methamphetamine overdose?

Naloxone reverses opioid effects, not methamphetamine toxicity. It can still be lifesaving if opioids were also taken or an unknown product contained them. Call 911 for a suspected overdose. An unresponsive person who is not breathing normally needs immediate dispatcher-guided CPR, regardless of the suspected drug. [1], [4]

Should treatment stop if methamphetamine use happens again?

A return to use should prompt a safety assessment and review of the treatment plan, not automatic abandonment of care. Discuss what happened, whether new symptoms require urgent help, and what support needs changing. Continuing engagement remains important even when abstinence has not yet been achieved. [9]

Editorial evidence

Evidence & sources

Selected clinical guidelines, peer-reviewed research, and public-health sources used in this article.

01ASAM/AAAP: The Clinical Practice Guideline on the Management of Stimulant Use DisorderView source
02SAMHSA TIP 33, Updated 2021: Chapter 2, How Stimulants Affect the Brain and BehaviorView source
03MedlinePlus Medical Encyclopedia: Methamphetamine OverdoseView source
View all 10 sourcesShow fewer sources
04MedlinePlus Medical Encyclopedia: CPR, Adult and Child After Onset of PubertyView source
05SAMHSA TIP 33, Updated 2021: Chapter 3, Medical Aspects of Stimulant Use DisordersView source
06SAMHSA TIP 33, Updated 2021: Chapter 4, Approaches to TreatmentView source
07FDA: Prescription Stimulant Medications, Evidence-Based Treatments for Stimulant Use DisordersView source
08Trivedi and colleagues: Bupropion and Naltrexone in Methamphetamine Use Disorder, New England Journal of Medicine, 2021View source
09SAMHSA TIP 33, Updated 2021: Chapter 5, Practical Application of Treatment StrategiesView source
10MedlinePlus Medical Encyclopedia: Suicide and Suicidal BehaviorView source
What this includes
01

Clinical context

Clear information is framed around complex and co-occurring presentations.

02

Individual factors

Assessment remains essential because needs and risks differ from person to person.

03

Next steps

A confidential conversation can help clarify the most appropriate route forward.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care